Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business. And ...

Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...

UBS has upgraded AstraZeneca (NASDAQ:AZN) to buy from neutral, stating it believes the company's in-market growth potential has been underestimated. The investment bank said its forecasts for the ...

Bind Research has launched as a not-for-profit focused research organization (FRO) with the aim of transforming disordered proteins into viable drug targets. The organization has secured financing ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

Bind Research launched to transform disordered proteins into effective drug targetsUK’s first not-for-profit Focused Research Organisation ...

Two women were arrested for offering drugs and prostitution at a Palm Beach bar after an undercover sting operation.

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand ...

SALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, ...

Dr. Joseph Bocka, Lana Royer, Elaine Surber and Laura Montgomery from Catalyst Life Services. The team shared their thoughts on January being designated National Substance Use Disorder Treatment Month ...

LinkedIn founder Reid Hoffman and Siddhartha Mukherjee, cancer researcher and author of the book “The Emperor of All Maladies,” have co-founded an AI-powered drug discovery startup ...